Dexmedetomidine Induced Polyuria in the Intensive Care Unit | Zendy

Mohammed Uddin | Zendy; Joseph Sebastian | Zendy; Muhammad Usama | Zendy; Fazal Raziq | Zendy; Ghulam Saydain | Zendy; Noreen F. Rossi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dexmedetomidine Induced Polyuria in the Intensive Care Unit

Author(s) -

Mohammed Uddin,

Joseph Sebastian,

Muhammad Usama,

Fazal Raziq,

Ghulam Saydain,

Noreen F. Rossi

Publication year - 2021

Publication title -

case reports in critical care

Language(s) - English

Resource type - Journals

eISSN - 2090-6439

pISSN - 2090-6420

DOI - 10.1155/2021/8850116

Subject(s) - dexmedetomidine , polyuria , medicine , intensive care unit , sedation , intensive care medicine , anesthesia , perioperative , diabetes insipidus , intensive care , pediatrics , diabetes mellitus , endocrinology

Dexmedetomidine is an α 2-adrenergic used as an adjunct therapy for sedation in the intensive care unit. While it is known to cause polyuria exclusively in perioperative conditions, not many cases are known in the intensive care unit, thus making the diagnosis challenging. We present the case of a 61-year-old male who had developed polyuria secondary to central diabetes insipidus after receiving dexmedetomidine intravenous infusion in the medical ICU. Increased awareness of this uncommon side effect of dexmedetomidine will help clinicians recognize and address it early.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research